SCHEMBL22914946

SCHEMBL22914946

CC(=O)c1ccc(C)c(NC(=O)c2cn(-c3ccc(F)c(O)c3)nn2)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KMT2A Q03164 1/20 0.48
DDT P30046 2/20 0.48
APP P05067 1/20 0.46
MIF P14174 1/20 0.43
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.41
RXRA P19793 4/20 0.39
GRIN1 Q05586 4/20 0.39
GRIN2B Q13224 4/20 0.39
TP53 P04637 1/20 0.38
WDR5 P61964 1/20 0.37
KDM1A O60341 1/20 0.37
NOTUM Q6P988 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22914919 0.89 DDT (0.50) NPC1RAB9ASMN1; SMN2KMT2ADDT
SCHEMBL29709845 0.89 DDT (0.50) NPC1RAB9ASMN1; SMN2KMT2ADDT
SCHEMBL22914933 0.82 APP (0.43) NPC1RAB9ASMN1; SMN2KMT2ADDT
SCHEMBL22914921 0.81 MAPT (0.51) NPC1RAB9ASMN1; SMN2KMT2ADDT
SCHEMBL29709874 0.81 MAPT (0.51) NPC1RAB9ASMN1; SMN2KMT2ADDT
SCHEMBL29709841 0.79 DDT (0.53) NPC1RAB9ASMN1; SMN2KMT2ADDT
SCHEMBL22914936 0.79 DDT (0.53) NPC1RAB9ASMN1; SMN2KMT2ADDT
SCHEMBL22914923 0.78 MAPT (0.47) NPC1RAB9ASMN1; SMN2KMT2ADDT
SCHEMBL22914925 0.78 DDT (0.49) NPC1RAB9ASMN1; SMN2KMT2ADDT
SCHEMBL29709834 0.78 MAPT (0.47) NPC1RAB9ASMN1; SMN2KMT2ADDT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021016594-A1 SECOND GENERATION INHIBITORS OF MITOCHONDRIAL PERMEABILITY TRANSITION PORE WITH IMPROVED PLASMA STABILITY OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-01-28 WO disclosed